Vendor, Reinach BL, CHE
Evolva AG
UEI USMKPLLM7GJ3, CAGE SAY72
1 award and $0 obligated between February 16, 2024 and February 28, 2026, 100% under full and open competition, against 6.0 offers on average where reported.
Industries
NAICS on the awards, by dollars.
| Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)NAICS 541715 | $0 |
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition | 1 |
| Definitive Contract | 1 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75D30122C15711Definitive Contract, February 16, 2024, Full and Open Competition, 6 offers | CDC Office of Acquisition ServicesCenters for Disease Control and Prevention | Development and Testing of Nootkatone-Containing Skin RepellentsNAICS 541715, PSC AJ11 | $0 |
- Product and service codes
- AJ11 General Science And Technology R&D Services; General Science And Technology; Basic Research
- Transactions
- 3 across 1 awards